Transcript for:
Midazolam (Versed) Overview

All right, you guys. Welcome back to another  video lesson from ICU Advantage. My name is   Eddie Watson and my goal is to give you guys  the confidence to succeed in the ICU by   making these complex, critical care subjects  easy to underst. I truly hope that I'm able   to do just that. And if I am, I do invite  you to subscribe to the channel down below. When you do, make sure you hit that bell  icon and select all notifications so you   never miss out when I release a new  lesson. All right. Now, real quick,   before we get started, I just wanted to  remind you guys again about the pre-order   opportunity for my new program that I'm very  excited about called ICU Advantage Academy. So many of you have actually come to YouTube  and my channel to learn and really grow   your knowledge base simply to become a better  practitioner and to do better for your patients,   which is absolutely amazing. But now I'm  actually working to become an approved   provider of CE credits and through ICU Advantage  Academy, you'll have the opportunity to earn CE   credits for watching all of these videos that I  made, as well as ones that I do in the future. Now. In addition to that, you're also gonna be  watching these videos without the interruption   of ads. You're gonna have access to audio only  versions of each video, as well as access to the   lesson notes for each one as well. So the academy  is gonna be officially launching March 15th,   but if you pre-order lifetime membership before  then, you're gonna save 50% off the launch. So don't miss out on a great deal  and opportunity for a really a   lifetime worth of learning and CE  credits for a limited time price. All right, so in this lesson we are  talking about Midazolam also goes   by the trade name verse Ed. So just a quick  history and background. This medication was   initially synthesized in 1975 by Walser  and Fry at Hoffman LAROCHE Incorporated,   and this is actually a Swiss  pharmaceutical company. And this was actually a favorable drug opposed  to some, you know, 35 other ish benzodiazepines   that are currently used in healthcare due to its  water solubility and really being less likely to   cause thrombophlebitis and then anticonvulsant.  Properties of midazolam were studied in the 1970s,   but it really wasn't recognized as an appropriate  treatment for status epilepticus until the 1990s. So Midazolam is a benzodiazepine that's  often used for the induction of anesthesia   and to produce conscious sedation for  its therapeutic actions. It's believed   that it works by binding GABA receptors  and really potentiating the effects of   endogenous gaba, which is a major inhibitory  neurotransmitter in the central nervous. Thus, it depresses the central nervous system.  It also works to suppress the spread of seizure   activity as well. Now for our indications, it  promotes perioperative sedation, anxiolysis,   anesthesia induction, or amnesia. It's also  used for the treatment of status epilepticus   in adults and typically in critical care  setting, we're either using it for procedural   sedation or for ongoing continuous sedation  in our intubated and ventilated patients. As for some contraindications,  obviously hypersensitivity to the   drug is gonna be. We do want to use  caution in older adults or patients   who are debilitated. Those really  with uncompensated acute illness,   heart failure, respiratory, renal, or  hepatic disease and those with increased   risk of falls. And then benzodiazepines  are associated with paradoxical reactions. So sometimes it can actually lead to agitation,  aggressive behavior as well as involuntary move.   now, as for our adverse effects, so again,  system by system for the central nervous   system. So one potential effect is gonna  be over sedation. Obviously drowsiness,   amnesia, seizures, potentially those involuntary  movements, paradoxical behaviors and excitement. For the cardiovascular system, we can see  variations in our patients' heart rate and   blood pressure. Although hypotension  is actually gonna be less common and   typically less severe when we're comparing  this to a medication like propofol. Now,   for E N T nystagmus is something  that we can see. For GI, nausea and   vomiting can potentially come about.  And then for our respiratory system,   big ones are gonna be decreased respiratory  rate, decreased oxygen, SATs, and apnea.   So as far as our common concentrations go  this medication does come in a PO form in   a a syrup. And, and typically you can see that in  a two milligram per ml in like a Hunter ML bottle. Or they do have some single use cups  of 10 milligrams in 5 MLs. So again,   another 2 milligram per ML concentration for IV  push. The most common concentration is gonna be   a one milligram per ML concentration, so two  milligrams, two mls, five milligrams, and five   mls. That said I believe there is some formulation  in which is a five milligram per ML concentration. Now for continuous sedation, typically again,  we're gonna see a 1 mg per ml concentration.   Something like 50 mg in 50 MLs, or a 100  mg in 100 MLs. now for our common dosing,   I'm gonna primarily focus on the, IV  form of this medication for IV pushes.   The dose really depends greatly on  the patient's clinical condition   as well as their potential tolerance to  the medication, as well as their size. But a push dose of one to two milligrams  is pretty common. But we certainly can't   also give larger doses as. For the IV infusion  again, really kind of depends on the use here,   but for sedation we're typically gonna start  out at around two milligrams per hour and   then titrate for a rascal. And ideally here  our max is gonna be 10 milligrams per hour. That said, some of you guys are  probably thinking that I'm crazy by   saying that cause you've seen it go much  higher. And this is absolutely the case,   especially for things like status epilepticus.  If they've got a brain injury and elevated ICPs,   if we're doing proning and paralytic therapy,  as well as other things in there as well. So we definitely can see higher doses than the 10  milligrams per hour. now for our pharmacokinetics,   again, for our IV administration, onsets  pretty quick, anywhere from 90 seconds to to   five minutes. Typically it tends to be on the  lower end of this, more towards 90 seconds. The   peak is anywhere from five to seven minutes, and  the duration is typically less than two hours. That said, with cirrhosis, we can see.  This actually go up to six hours. And the   reason for this is it is metabolized  primarily in the liver and the gut,   and it gets metabolized into four main  metabolites, all of which have various   roles in the effect of midazolam. And then  these metabolites do get excreted in the urine. Now, as far as our antidote goes, we do  have an antidote for this called omano,   also goes by the name Zicon, and here the dose is  gonna be 0.2 milligrams iv. now for our nursing   considerations. Now again, this should only be  administered by someone who's been specifically   trained and has the knowledge when using this  medication as a sedative for procedural sedation. So we wanna make sure that the, the  antidote, Ramas Flumazenil should   really be readily available in the  event that we do have over sedation,   which can lead to impaired respiratory status and  depression. That said, we also wanna make sure   we've got rescue equipment nearby. Again,  typically not an issue in the ICU U, but. You know, things like our code cart, bag, valve  mask suctioning can be really important as well   if we're, we're dealing with this, make sure that  you are monitoring your patient's blood pressure,   heart rate and rhythm, their respirations, their  airway integrity, and then make sure we've got a   continuous pulse oxs, especially if we're doing  the conscious sedation or procedural sedation. And then just be aware that individuals  that have underlying hepatic impairments   and cirrhosis that they may metabolize  this drug slower leading to a prolonged   duration of the drug as opposed to those  who have normal hepatic function. As well   as we do also want to be using decreased  dosing in patients who have renal failure. And here, typically we're looking at a 50%  decrease in the dose. And then finally, for   any relevant laboratory studies, there actually  aren't any identified with this medication.   And that is gonna be our review of Midazolam  aka ved. So I hope that you guys found this   information useful. If you did, please  leave me a like on the video down below. It really helps YouTube know to show  this video to other people out there,   as well as leave me a comment down below. I  love reading the comments that you guys leave,   and I try to respond to as many people as I  can. Make sure you subscribe to this channel   if you haven't. A special shout out to the  awesome YouTube and Patreon members out there,   the support that you're willing to show  me, and this channel is truly appreciated. So thank you guys so very much. If you'd  be interested in showing additional support   for this channel, you can find links to  both the YouTube and Patreon membership   down below. Head on over there and check  out some of the perks that you guys get   for doing just that. As well as check out  some of the links to other nursing gear,   as well as some awesome t-shirt  designs I have down there as well. Make sure you guys stay tuned for the  next lesson that I release. Otherwise,   in the meantime, here's a couple  awesome lessons I'm gonna link to   right here. As always, thank you guys  so much for watching. Have a great day.